Tata Chemicals Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Future Growth Expectations from Tata Chemicals Limited Q1 FY27 Earnings Call: - **India Business:** - Positive volume growth driven by demand across products. - Higher realization expected due to pricing adjustments linked to import parity. - Growth in salt volumes and favorable conditions in food, feed, pharma. - Focus on non-cyclical products like silica and specialty segments. - Expansion projects like 82.5 KTPA salt plant operational by year-end; silica plant by 2028. - **US Business:** - Stable domestic volumes with steady pricing; export volumes supported by LATAM and Northeast Asia. - Margins under pressure from logistics cost but volumes steady. - Southeast Asian export volume reduced due to Chinese competition. - **Global Soda Ash Market:** - Oversupply expected to continue, especially from China, keeping pricing subdued. - Long-term demand positive due to renewable energy and electrification focus. - LATAM demand strengthened with rising lithium carbonate production. - **IMACID Business:** - Operations resumed but margins under pressure due to high sulfur prices; expected profitability by year-end. - **Battery Segment:** - Sodium-ion battery piloting ongoing with plans for commercialization focused on stationary energy storage. Overall, volume growth is expected to be modest in challenging segments with strategic capital allocation towards non-cyclical, higher-value products ensuring sustainable revenue growth.

- For FY27, Tata Chemicals plans capex around the depreciation number (~INR 1,200 crores) and aims not to exceed it, preferably staying below. - No explicit mention of new debt or equity fundraising during the call. - The company has liquidated INR 300 crores of investments (shares and non-core land) in Q1, which helped reduce debt. - There is ongoing exploration of monetizing additional non-core land in the second half of FY27 and possibly other non-core assets if needed. - No specific plans disclosed regarding raising new debt or equity; the focus is on managing capex within depreciation and optimizing asset monetization. Hence, no current or immediate plans for new debt or equity fundraising were communicated.

The transcript provided from Tata Chemicals Limited's Q1 FY27 earnings call does not mention any details regarding the current or expected order book or pending orders. There is no information or discussion on order backlog, order inflow, or pending contracts in the text on pages 1 through 15 of the document. The focus is primarily on operational performance, market outlook, product segments, pricing, raw material cost, capex plans, and technology development such as sodium-ion batteries. Hence, no data or commentary related to order book or pending orders is available from the given transcript.